On Tuesday, pharmaceutical company AstraZeneca announced that it would withdraw its COVID-19 vaccine. In a statement, AstraZeneca said it would begin to withdraw Vaxzevria’s authorizations within Europe over low demand. This particular vaccine was not approved in the United States. "As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said in a statement, according to Fox Business. "Our efforts have been recognized by governments around the world and are widely regarded as being a critical component of ending the global pandemic," the statement continued. "We will now work with regulators...